Navigation Links
Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
Date:2/28/2011

d in a durable improvement in total CD4+ T-cell counts in five of six of the subjects analyzed.  In addition, five of the six subjects also exhibited sustained improvements in their CD4:CD8 T-cell ratio, which is an indicator of immunologic health. The ZFN-CCR5-modified cells also exhibited normal T-cell growth kinetics and trafficking and were observed to undergo selective expansion in the gut mucosa, a major reservoir of virus in the body, suggesting, as predicted, that the cells were resistant to HIV infection. These data represent the necessary first steps in the development of a "functional cure" for HIV/AIDS by providing a protected CD4+ T-cell population in these subjects that is resistant to HIV infection.

The presentation will be made at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) which is being held in Boston from February 27 to March 2, 2011.  In a late-afternoon session on Wednesday, March 2, 2011, Dr. June will present further data from Sangamo's Phase 1 trials of SB-728-T and Paula Cannon, Ph.D., Associate Professor of Molecular Microbiology & Immunology at the Keck School of Medicine of the University of Southern California (USC), will present preclinical data from Sangamo's program of ZFN-modification of the CCR5 receptor in hematopoietic stem cells.  Also at CROI, Sangamo's collaborators at the University of Pennsylvania will describe preclinical data from a program to modify the CXCR4 gene in human CD4+ T-cells. More information about these presentations will be available later in the week.

"These data represent the beginning of a new hope for HIV therapy," said Jacob Lalezari, M.D., the Director of Quest Clinical Research, Assistant Clinical Professor of Medicine at Mount Zion Hospital, UCSF, and one of the principal investigators of the study. "This approach aims to provide a protected reservoir of HIV-resistant T-cells that are available to fight infections including the virus.  I
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
10. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
11. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015  IBM Watson Health (NYSE: IBM ) ... and Mayo Clinic to advance patient health by ... Records (EHRs). As Watson,s capabilities are applied ... thorough analysis of the medical factors that could impact an ... than 350 customers – some of the largest and most-recognized ...
(Date:5/5/2015)... 2015 Research and Markets ( ... "Radiation Dose Management Market by Product (Dose ... Application (Computed Tomography, Angiography, Fluoroscopy), by End User ... report to their offering. The ... grow at a CAGR of around 50% during ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... the "Home Healthcare Global Market - Forecast to ... home healthcare market is expected to reach more than ... The home healthcare equipment market is expected ... healthcare services market. Home healthcare is gaining a tremendous ...
Breaking Medicine Technology:IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 2IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 3IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 4Radiation Dose Management (Dose Tracking, Monitoring, and Analytics Software, Consulting Services) Market - Global Forecasts to 2020 2Radiation Dose Management (Dose Tracking, Monitoring, and Analytics Software, Consulting Services) Market - Global Forecasts to 2020 3Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2
(Date:5/5/2015)... 2015 Horizon Blue Cross Blue Shield ... secure credit rating of “A” from Standard & Poor’s. ... week, the Wall Street ratings agency cited the company’s ... in determining the rating and “stable” outlook. , “Providing ... our top priorities, so we are pleased to have ...
(Date:5/5/2015)... May 05, 2015 Hundreds ... filed on behalf of men who allegedly ... use of prescription testosterone replacement therapies continue ... litigation underway in U.S. District Court, Northern ... dated May 1st, defendants AbbVie, Inc., Auxilium ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great conditions last ... walkers participated in Global Lyme Alliance’s (GLA) inaugural “Lyme ... 5K and 10K runs and 1-and 3-mile walks were held ... for tick-borne disease research. The “Lyme Walk and Run” was ... of Lyme Research Alliance (LRA) and Tick-Borne Disease Alliance (TBDA), ...
(Date:5/5/2015)... Battle Creek, Michigan (PRWEB) May 05, 2015 ... IN, media outlet The Herald-Times , the Missouri State ... incidents involving Crystal Methamphetamine production or use for the second ... national meth statistics to the FBI, reported 1,469 incidents in ... this into perspective, only around 2% of the US Population ...
(Date:5/5/2015)... 05, 2015 The brains of people ... that correlate with slower information processing, according to research ... of Public Health . , The findings indicate ... 1 diabetes for cognitive difficulties. If progressive, these changes ... study, funded by the National Institutes of Health ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4
... Environmental agencies in Tamil Nadu are demanding monitoring stations ... samples //from the state among the most polluted in ... Pollution Control Board to apply for central funds to ... monitoring stations in Manali, Mettur, Cuddalore, Tuticorin and other ...
... condition of VHP leader Praveen Togadiya, who underwent an angioplasty ... hospital sources said today. // ,Togadiya was admitted ... ,Cardiologist of the Hospital Dr Bhupesh Shah carried out the ... at the hospital, the condition of the leader is stable ...
... University in California, monstrous matter-sucking black holes in the space ... research//. ,When used in a car it will ... gallon (4.5 litres) of gas. ,Huge bubbles in ... or even thousands of light-years across. ,Allen and ...
... University's Vegetable and Fruit Improvement Center researchers revealed when ... it improves bone strength and prevents osteoporosis//. ... women in the United States, according to the National ... wrists break each year as a result, said Dr. ...
... resistant to mad cow disease. The success story was ... eastern province of Shandong ,Researchers at the Laiyang ... to introduce the genes to the calf cloned from cells ... Dong Yajuan and Bo Xuejin , who had first tasted ...
... attack for the time and has survived cannot be termed as ... them//. A new study has found that one out of ten ... of blood to be pumped to the vital organs. As a ... organs stop functioning. It is said that cardiogenic shock is the ...
Cached Medicine News:Health News:Air Pollution in Tamil Nadu is a Cause of Concern for Environmentalists 2Health News:Bone Strength Increases In Rats With Citrus Juice Breakfast – Study Say 2Health News:Cardiogenic Shock is the Leading Cause of Death for Heart Attack Patients 2Health News:Cardiogenic Shock is the Leading Cause of Death for Heart Attack Patients 3
... RELISA ENA Single Well Screening Kit is designed ... most common autoantibodies. Each microtiter well is coated ... autoantigens. This allows the laboratory to cost effectively ... to determining the ENA specificity on any of ...
The K-ASSAY Rheumatoid Factor Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifying...
... Lipid Control is intended for use in ... sample of known concentration for monitoring assay ... Liquid Lipid Control with patient serum specimens ... constituents. The user can compare observations with ...
The K-ASSAY Lp(a) Control Set is intended for use as an assayed quality control material for monitoring the performance of Lp(a) immunoturbidimetric assays....
Medicine Products: